APP and Alzheimer disease: Another study is one investigating lysosomal autophagy pathways in AD mouse models, demonstrating that metformin acts as an activator of chaperone-mediated autophagy, a form of lysosomal autophagy that binds to and degrades amyloid precursor protein (APP), thereby increasing the clearance of APP and decreasing the accumulation of Aβ [47].